Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    23816967 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
Conditions: Carcinoma, Non-Small-Cell Lung;   Adenocarcinoma
Interventions: Drug: Pemetrexed;   Drug: BIBW 2992;   Drug: Cisplatin

Study has passed its completion date and status has not been verified in more than two years.